rs150129110

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_001353921.2(ARHGEF9):​c.582C>T​(p.His194His) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000029 in 1,206,552 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 8 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.000072 ( 0 hom., 1 hem., cov: 22)
Exomes 𝑓: 0.000025 ( 0 hom. 7 hem. )

Consequence

ARHGEF9
NM_001353921.2 splice_region, synonymous

Scores

3
Splicing: ADA: 0.001070
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.0990

Publications

1 publications found
Variant links:
Genes affected
ARHGEF9 (HGNC:14561): (Cdc42 guanine nucleotide exchange factor 9) The protein encoded by this gene is a Rho-like GTPase that switches between the active (GTP-bound) state and inactive (GDP-bound) state to regulate CDC42 and other genes. This brain-specific protein also acts as an adaptor protein for the recruitment of gephyrin and together these proteins facilitate receceptor recruitement in GABAnergic and glycinergic synapses. Defects in this gene are the cause of startle disease with epilepsy (STHEE), also known as hyperekplexia with epilepsy, as well as several other types of cognitive disability. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2017]
ARHGEF9 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 8
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001353921.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant X-63697125-G-A is Benign according to our data. Variant chrX-63697125-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 385107.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.099 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 7 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001353921.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARHGEF9
NM_001353921.2
MANE Select
c.582C>Tp.His194His
splice_region synonymous
Exon 4 of 10NP_001340850.1A0A5F9ZHY9
ARHGEF9
NM_001353923.1
c.600C>Tp.His200His
splice_region synonymous
Exon 4 of 10NP_001340852.1A0A1B0GWI5
ARHGEF9
NM_001369030.1
c.561C>Tp.His187His
splice_region synonymous
Exon 5 of 11NP_001355959.1O43307-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ARHGEF9
ENST00000671741.2
MANE Select
c.582C>Tp.His194His
splice_region synonymous
Exon 4 of 10ENSP00000500715.1A0A5F9ZHY9
ARHGEF9
ENST00000253401.10
TSL:1
c.561C>Tp.His187His
splice_region synonymous
Exon 4 of 10ENSP00000253401.6O43307-1
ARHGEF9
ENST00000374878.5
TSL:1
c.582C>Tp.His194His
splice_region synonymous
Exon 4 of 10ENSP00000364012.2B1AMR4

Frequencies

GnomAD3 genomes
AF:
0.0000719
AC:
8
AN:
111218
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.0000327
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000477
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00135
GnomAD2 exomes
AF:
0.0000910
AC:
16
AN:
175856
AF XY:
0.0000490
show subpopulations
Gnomad AFR exome
AF:
0.0000781
Gnomad AMR exome
AF:
0.000374
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000246
AC:
27
AN:
1095334
Hom.:
0
Cov.:
30
AF XY:
0.0000194
AC XY:
7
AN XY:
361294
show subpopulations
African (AFR)
AF:
0.0000760
AC:
2
AN:
26328
American (AMR)
AF:
0.000344
AC:
12
AN:
34921
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19298
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30115
South Asian (SAS)
AF:
0.000168
AC:
9
AN:
53655
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40376
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4096
European-Non Finnish (NFE)
AF:
0.00000238
AC:
2
AN:
840596
Other (OTH)
AF:
0.0000435
AC:
2
AN:
45949
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000719
AC:
8
AN:
111218
Hom.:
0
Cov.:
22
AF XY:
0.0000299
AC XY:
1
AN XY:
33458
show subpopulations
African (AFR)
AF:
0.0000327
AC:
1
AN:
30586
American (AMR)
AF:
0.000477
AC:
5
AN:
10482
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2642
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3498
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2619
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5990
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
239
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
52995
Other (OTH)
AF:
0.00135
AC:
2
AN:
1485
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.539
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000285
Hom.:
1
Bravo
AF:
0.000136

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Developmental and epileptic encephalopathy, 8 (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
not provided (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
0.79
DANN
Benign
0.50
PhyloP100
-0.099
Mutation Taster
=72/28
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0011
dbscSNV1_RF
Benign
0.13
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs150129110;
hg19: chrX-62917005;
COSMIC: COSV53638250;
COSMIC: COSV53638250;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.